Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 21;9(7):e17492.
doi: 10.1016/j.heliyon.2023.e17492. eCollection 2023 Jul.

Elevated follicular cortisone level is a negative predictor of clinical pregnancy in women undergoing fresh embryo transfer

Affiliations

Elevated follicular cortisone level is a negative predictor of clinical pregnancy in women undergoing fresh embryo transfer

Zuwei Yang et al. Heliyon. .

Abstract

Background: Although numerous studies have investigated the potential correlation between follicular fluid (FF) steroid concentrations and in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) outcomes, few have accounted for the effect of controlled ovarian hyperstimulation regimes on FF steroid concentrations.

Objective: To comprehensively compare follicular steroid concentrations between women stimulated with gonadotropin-releasing hormone agonist (GnRHa) and antagonist (GnRHant) protocols and to explore the associations between FF steroid concentrations and IVF/ICSI outcomes.

Methods: A total of 295 infertile women undergoing IVF/ICSI from January 2018 to May 2020 were enrolled. Eighty-four and 211 women received GnRHa and GnRHant protocols, respectively. Seventeen steroids in FF were quantified by liquid chromatography tandem mass spectrometry (LC-MS/MS), and the correlation of follicular steroids with clinical pregnancy was explored.

Results: Follicular steroid concentrations were similar between the GnRHa and GnRHant groups. Follicular cortisone levels were adversely associated with clinical pregnancy in fresh embryo transfers. Receiver operating characteristic (ROC) analysis revealed an area under the ROC curve (AUC) of 0.639 (95% confidence interval = 0.527-0.751, p = 0.025) for predicting non-pregnancy, with an optimal cutoff value of 15.81 ng/mL (sensitivity = 33.3%, specificity = 94.1%). Women with FF cortisone concentrations ≥15.81 ng/mL were fifty times less likely to achieve clinical pregnancy in fresh embryo transfers than those with FF cortisone levels below this threshold (adjusted OR = 0.019, 95% confidence interval = 0.002-0.207, p = 0.001) after adjusting for age, body mass index, baseline serum progesterone levels, serum levels of luteinizing hormone, estradiol and progesterone on human chorionic gonadotropin day, ovarian stimulation protocols, and the number of transferred embryos.

Conclusions: There was no significant difference in intrafollicular steroid levels between GnRHa and GnRHant protocols, and intrafollicular cortisone level ≥15.81 ng/mL was found to be a strong negative predictor of clinical pregnancy in fresh embryo transfers with high specificity.

Keywords: Assisted reproduction technology; Clinical pregnancy; Cortisone; Follicular fluid; LC-MS/MS.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Clinical pregnancy rates in fresh/frozen embryo transfer across FF cortisone quartiles. Clinical pregnancy rates across FF cortisone quartiles were statistically different in fresh embryos transfers (p = 0.042), but comparable in frozen embryo transfers (p = 0.925). Abbreviations: ET, embryo transfer.
Fig. 2
Fig. 2
ROC curve of FF cortisone levels on the probability of non-pregnancy in fresh embryo transfer. The area under curve (AUC) was 0.639 (95% confidence interval = 0.527–0.751, p = 0.025). The optimal cutoff value of FF cortisone levels was 15.81 ng/mL (sensitivity = 33.3%, specificity = 94.1%).

Similar articles

References

    1. Dumesic D.A., Meldrum D.R., Katz-Jaffe M.G., Krisher R.L., Schoolcraft W.B. Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health. Fertil. Steril. 2015;103:303–316. doi: 10.1016/j.fertnstert.2014.11.015. - DOI - PubMed
    1. Piccinni M.P., Vicenti R., Logiodice F., Fabbri R., Kullolli O., Pallecchi M., Paradisi R., Danza G., Macciocca M., Lombardelli L., Seracchioli R. Description of the follicular fluid cytokine and hormone profiles in human physiological natural cycles. J. Clin. Endocrinol. Metabol. 2021;106:e721–e738. doi: 10.1210/clinem/dgaa880. - DOI - PMC - PubMed
    1. Chou C.H., Chen M.J. The effect of steroid hormones on ovarian follicle development. Vitam. Horm. 2018;107:155–175. doi: 10.1016/bs.vh.2018.01.013. - DOI - PubMed
    1. Brinca A.T., Ramalhinho A.C., Sousa Â., Oliani A.H., Breitenfeld L., Passarinha L.A., Gallardo E. Follicular fluid: a powerful tool for the understanding and diagnosis of polycystic ovary syndrome. Biomedicines. 2022;10:1254. - PMC - PubMed
    1. Chen A. Follicular fluid metabolome: a better alternative than serum metabolome for new insights on reproductive health? Fertil. Steril. 2022;118:980–981. doi: 10.1016/j.fertnstert.2022.09.028. - DOI - PubMed

LinkOut - more resources